Latest news with #Flatiron
Yahoo
7 hours ago
- Entertainment
- Yahoo
Ski-inspired Workout Nordic Strong Lands in New York
Skiing just became a summer sport. Nordic Strong, a Copenhagen-based ski workout concept, has made its way to New York. This summer, the brand will be hosting a pop-up fitness studio in Sag Harbor at 11 Bridge Street until Labor Day, followed by a permanent outpost in Flatiron at 35 West 21st Street in Manhattan in early September. A single drop in class costs $50. More from WWD Inside Puppy Sphere, the Endorphin-boosting Non-workout Yoga Class Inside Pride x Boom, New York Pride Weekend's Kick-off Party Watermill Center Unveils 'Upside Down Zebra,' a Celebration of Childhood Art and Contemporary Creativity Nordic Strong employs a patented machine, which the fitness brand now owns, that replicates cross-country skiing. The machine can create 50-plus low-impact, full-body workouts and can be customized in a variety of ways. 'We found our first location in Copenhagen and opened that two years ago as a proof of concept. We knew we wanted to take it to the U.S.,' saya Nordic Strong founder and chief executive officer Nicole Roth. 'All classes are centered around the machine, but because it's so versatile we use it in different ways. We do a strength class, a cardio class and a sculpt class that's Pilates-based.' Each class is 50 minutes and also may employ mat work, weights and Bala accessories. Inspired by its Copenhagen roots, the space incorporates a cozy, Nordic-esque design, while the classes feature custom color lights inspired by the Northern lights. Roth described the concept as 'rooted in the Nordic heritage, but still globally relevant.'
Forbes
18-06-2025
- Entertainment
- Forbes
The Longest Sushi Bar In New York Is Now Open In Flatiron
The stunning sushi bar is the longest in NYC. You can't swing a sashimi knife in Manhattan without hitting an omakase counter these days. But Aqua Kyoto, the Japanese dining room inside Aqua New York in Flatiron, isn't just adding to the pile. It's carving out something bigger—literally. They've opened what's now the city's longest sushi bar. It stretches a staggering 77 feet. Yes, feet. This thing could double as a runway during Fashion Week. The sushi bar anchors the Kyoto side of Aqua New York's dual-restaurant setup, which also includes Aqua Roma (Italian, naturally). The bar feels theatrical—expansive without being cold—and, surprisingly, doesn't overpower the food or the experience. You'd expect something this size to turn into a gimmick. It doesn't. At the 22-seat counter, Chef Mitsuru Hara serves up a ten-course omakase that's equal parts sharp technique and unfussy pleasure. It's $158 for the full ride, and nothing feels inflated—either in portion size or pretension. Things kick off with a spinach salad dressed tableside with toasted sesame. It's not showy, but it lands. Then comes a Tuna and Salmon Tartar with a hit of caviar, a bit of yuzu kosho, and some wonderfully crispy lotus root chips. It's precise, not precious. Sushi purists and skeptics alike will find something to like here. The Scallop & Caviar Crystal Sushi is a standout—not just for the glimmering jelly on top (which, yes, sounds ridiculous) but for the subtle flavor it brings. Then there's the Spicy Tuna Maki. You've had a thousand of them, sure. This one's better—clean, punchy, nothing dripping in sauce or buried under fried onions. The Prawn Tempura is textbook in the way you want it to be: crisp, greaseless, salted with matcha, and dipped in a ten-tsuyu that's warming but restrained. The Miso Black Cod? You've had it before, yes, but here it feels grown-up—less sweet, more elegant, with just enough char to remind you it's been tended to. And then there's dessert. "Forest Floor," it's called, and it sounds like a Pinterest board. But the execution is surprisingly restrained: Tonka bean panna cotta, chocolate brownie crumble, a matcha soil, and a tart raspberry sorbet that cuts through the sweetness like a sharp exit line. It's plated like something out of a Nordic tasting menu, but—mercifully—tastes like dessert. Optional sake pairings are available, and they're worth the extra cost. They're not overly explained or turned into a seminar, which is a blessing these days. Just well-matched pours that make sense with the food. But the bar—and the meal—are only part of what Aqua New York is offering. This is a dual-concept restaurant, after all, where Aqua Kyoto shares space with Aqua Roma, a modern Italian operation located just across the dining room. And here's where things get interesting: you can order from either side of the menu no matter where you sit. Sushi followed by osso buco? Absolutely. Uni with your burrata? Nobody will stop you. The Italian side, Aqua Roma, focuses on seasonal regional fare and features a strong wine program built around a newer generation of small-production Italian winemakers. The Japanese side leans into contemporary Kyoto-style cuisine with an emphasis on seasonality and clean flavors. It's not fusion. It's a culinary two-hander. And somehow, it all plays well together. It helps that the dining room is a spectacle. The sushi bar might be the longest, but the central oval cocktail bar—Aqua Spirit—makes a bid for the largest in the city. It's a vast, curving statement piece, and yet it doesn't make you feel like you've wandered into a casino. It just feels... generous.
Eater
17-06-2025
- Entertainment
- Eater
A ‘Top Chef' Winner's Flatiron Restaurant Closes After Less Than a Year
Flatiron's Time and Tide closes today following its debut in October 2024. The upscale Flatiron fish house from Kent Hospitality and Top Chef winner Danny Garcia will reopen as a new concept from the same team — but an unexpected residency will be in the space until then. After a kitchen fire closed neighboring Massara on June 11, the Southern Italian spot from chef Stefano Secchi and his partner, David Switzer, will pop up at 48 E. 26th Street, at Park Avenue South, starting Thursday, June 19, until further notice, while the original Massara location undergoes repairs at its 913 Broadway location. It will be called Massara on Park, with reservations available on Resy. The menu will feature many familiar signature dishes inspired by the coast of Campania as well as new ones — particularly with a focus on crudo for the summer. 'Kent Hospitality Group is lending a helping hand to its friends at Massara … after a fire caused their original location to close indefinitely,' a spokesperson told Eater over email. 'During this time, KHG and Chef Danny Garcia will reimagine the Time and Tide concept.' 'We are extremely grateful no one was injured and for the FDNY's rapid response,' said Secchi in a statement to Eater. 'As rebuilding Massara will likely take a few months, our entire team is grateful to our friends at Kent Hospitality Group.' The cause of the kitchen fire at Massara is still under investigation. For perspective on how long the repairs could take, a fire at New York's Gjelina shortly after it opened in 2023 shut down the famous restaurant from Los Angeles for almost two years. Time and Tide seemed to be struggling to get its sea legs, with Saga and Crown Shy restaurateur Jamal James Kent and Garcia originally collaborating on the restaurant before Kent's untimely death last June. The original fish and seafood-filled menu was based on Kent's summer memories of his grandmother's home in Sag Harbor and Garcia's summers in Fire Island, with elements of seaside memories woven throughout the restaurant. However, a menu overhaul last month added more international dishes like grilled dates and frena bread with labneh, chicken katsu, and skate muhammara. Time and Tide was the first solo project from Top Chef Winner Garcia, and the first restaurant opened by Kent Hospitality Group following the unexpected passing of its namesake founder. Time and Tide was one of the most anticipated restaurant openings of 2024. Since Kent's death, the restaurants from Kent Hospitality group have shifted to reflect emerging leaders, with Michelin-starred Crown Shy overseen by Jassimran Singh, two-star Saga overseen by Charlie Mitchell, and World's 50 Best bar with a spectacular view, Overstory from Harrison Ginsberg. The team's largest undertaking yet has been overseeing the operations for several hospitality projects inside the Financial District's luxurious new department store, Printemps, including Maison Passerelle and Salon Vert — both overseen by James Beard winner Gregory Gourdet. The group is also behind the newly opened Birdee, the Brooklyn bakery in the Domino development from pastry chef Renata Ameni. Earlier this year, the Times reported Billy Durney, of Hometown Bar-B-Que and Red Hook Tavern acclaim, has taken on investment from Kent Hospitality, and will open a restaurant with the group at 9 West 57th Street. And earlier this month, the group signed to open a place in the former Bistro Les Amis space in Soho, which will be a bar overseen by Ginsberg. The timing lines up for now: Garcia is reworking his first spot just as Massara loses its home, but it's anyone's guess whether the two will sync up again when it's time for the Italian restaurant to return. See More:
Business Wire
22-05-2025
- Business
- Business Wire
CORRECTING and REPLACING Flatiron Health Announces Research to Be Presented at ASCO 2025
NEW YORK--(BUSINESS WIRE)--Please remove the partners listed under "Real-world (rw) ctDNA testing trends and associated outcomes in patients (pts) with early stage breast cancer (EBC)." Our research accepted at this year's ASCO demonstrates our lasting commitment to deliver actionable evidence and improve care for every person with cancer. Share The updated release reads: FLATIRON HEALTH ANNOUNCES RESEARCH TO BE PRESENTED AT ASCO 2025 Flatiron's 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence, address health equity, and accelerate progress in cancer care and clinical research. Flatiron Health today announced 14 abstracts leveraging its high-quality real-world oncology data have been accepted for poster presentation and online publication at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. These studies exemplify Flatiron's commitment to advancing cancer research and align with this year's ASCO theme, 'Driving Knowledge to Action: Building a Better Future,' by delivering critical evidence to inform and improve patient care. 'AI and related technologies have enabled us to unlock data and insights from our entire network of over five million people with cancer, providing unprecedented scale, efficiency, and innovation for both real-world evidence generation and clinical trial execution,' said Stephanie Reisinger, Senior Vice President & General Manager, Real-World Evidence. 'Our research accepted at this year's ASCO demonstrates our lasting commitment to deliver actionable evidence and improve care for every person with cancer.' Highlights include: a poster presentation utilizing advanced machine learning models to identify a cohort of over 195,000 to complete the largest real-world study to date examining ctDNA testing in early stage breast cancer an abstract assessing how often PSMA-PET scans were used among non-Latinx/Hispanic White, Black, and Latinx patients with metastatic prostate cancer an abstract demonstrating the potential of a centralized, tech-enabled screening service to make clinical trial enrollment and more efficient, particularly in community oncology settings Schedule a meeting with Flatiron Health at ASCO 2025, and learn more about our abstracts and events, including workshops and panels. Follow Flatiron Health on X and LinkedIn for more updates from #ASCO25 and visit us in person at Booth #11131. Partners: Memorial Sloan Kettering Cancer Center, AstraZeneca Dana Rathkopf, Danni Zhao, Lana Kovacevic, Jenna Collins, Eunice Hankinson, Helen Marshall, Aaron Springford, Simran Shokar, Helene von Bandemer, Weiyan Li Genitourinary—Prostate, Testicular, and Penile Poster board: 295 Abstract number: 5096 Impact of social determinants of health on mortality in diffuse large B-cell lymphoma (DLBCL) using real-world data Partners: Yale School of Medicine, University of Alabama at Birmingham, Fox Chase Cancer Center, University of Texas Southwestern Medical Center, University of Colorado at Anschutz Maureen Canavan, Mengru Wang, Olive Mbah, Maneet Kaur, Michael J. Hall, Adeel Khan, Jessica McDermott, Madeline Schmitter, Anosheh Afghahi, Gaurav Goyal Quality Care/Health Services Research Poster board: 436 Abstract number: 11097 Partners: UCLA, AstraZeneca, Memorial Sloan Kettering Cancer Center, The University of Chicago Jay Lee, Daniel Simmons, Tiernan Mulrooney, Jeremy Snider, Lana Natalija Kovacevic, Karen Schwed, Aditya Juloori Lung Cancer—Non–Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Poster board: 199 Abstract number: 8078 Molecular residual disease (MRD) in solid tumors Partners: Taylor Cancer Research Center, Exact Sciences, Case Comprehensive Cancer Center Majd T. Ghanim, John Nemunaitis, Tara Marti, Abhishek Dabral, Katherine Diaz-MacInnis, Judith Frederick, Marla Kuleszynski, Yichen Lu, Amanda Rodriguez-Sullivan, Melanie Palomares, Natalie Salituro, Soma Subramaniam, Anthony Tate, Kathleen Turnbull, Neal J. Meropol Therapeutics—Molecularly Targeted Agents and Tumor Biology Poster board: 486b Abstract number: TPS3186 Assessment of racial/ethnic inequities in uptake of Prostate Specific Membrane Antigen - Positron Emission Tomography (PSMA-PET) scans among patients with metastatic prostate cancer in the United States (US) Eunice A. Ochuonyo, Samantha Reiss, Patrick J. Ward, Brooke A. Jarrett, Olive Mbah, Prakirthi Yerram, Laura Rivera-Reyes, Sophia Miller, Kelly Magee, Lynn Rosario, Wendy Wittman, Cleo A. Ryals Online publication only Accrual of racially and ethnically underrepresented populations with multiple myeloma associated with centralized patient screening in a multicenter study Partners: University of Colorado, Johnson & Johnson, New York Cancer and Blood Specialists Anosheh Afghahi, Daniel Sanchez, Yichen Lu, Richard M. Zuniga, Laura Heste, Dina Gifkins, Britney Beaulieu, Catharine Cipolla, Barry Leybovich, Debra Mitchell, Jeffrey Nan, Ebube Onwasigwe, Hemang Patel, Paul Salcuni, Chloe Salzman, Neal J. Meropol, Ashita S. Batavia Online publication only A retrospective real-world study of first-line PD-(L)1 inhibitor use in patients with metastatic non-small cell lung cancer (mNSCLC) Partner: Incyte Kim Saverno, Siobhan Halloran, Mark Guinter, Kelly Magee, Michael Ondovik, J.E. Hamer-Maansson, Mark Cornfeld, Mihaela Munteanu Online publication only A retrospective cohort study of real-world clinical outcomes in patients with CLL/SLL previously treated with covalent BTK inhibitor (cBTKi) and BCL2 inhibitor (BCL2i) regimens Partners: Merck & Co, MSD UK, Mayo Clinic Jennifer Prescott, Christina Parrinello, Ahmed Sawas, Enrico De Nigris, Jing Yang, Erik Bloomquist, Indu Shrivastava, Changxia Shao, Xinyue Liu, Mohammed Farooqui, Sameer A. Parikh Online publication only Management and outcomes of rash, peripheral neuropathy (PN), and hyperglycemia (HG) during first-line (1L) treatment (Tx) of locally advanced/metastatic urothelial cancer (la/mUC) in a real-world setting Partners: Cleveland Clinic, Merck KGaA, EMD Serono Amanda Nizam, Mairead Kearney, Valerie Morris, Seyed Hamidreza Mahmoudpour, Carroline Lobo, Chiemeka Ike, Jason Hoffman, Ilian Iliev, Prakirthi Yerram, Mark Guinter Online publication only Concordance of response-based clinical trial and machine learning–generated real-world end points Partner: Genentech Qianyi Zhang, Konstantin Krismer, Yichen Lu, Qianyu Yuan, Aaron Dolor, Auriane Blarre, Aaron B. Cohen, Tori Williams, Sophia Maund, Minu K. Srivastava, Kelly Magee Online publication only Partners: Pfizer, University of San Francisco Helen Diller Family Comprehensive Cancer Center, MD Anderson Cancer Center, Dana-Farber Cancer Institute, European Institute of Oncology IRCCS, University of Milano, UPMC Hillman Cancer Center Hope S. Rugo, Rachel M. Layman, Filipa Lynce, Xianchen Liu, Benjamin Li, Lynn McRoy, Aaron B. Cohen, Melissa Estevez, Giuseppe Curigliano, Adam Brufsky Online publication only Unmet need in adults and adolescents and young adults (AYAs) with B-cell acute lymphoblastic leukemia (B-ALL) in the US following a second relapse Partners: Memorial Sloan Kettering Cancer Center, Stanford Cancer Center, AstraZeneca, Tampa General Hospital Cancer Institute, Knight Cancer Institute, MD Anderson Cancer Center Mark B. Geyer, Michaela Liedtke, Vikram Shetty, Anthony Proli, Yazan K Barqawi, Jenna Collins, Nikesh N. Shah, Jessica T. Leonard, Joseph Elias Jabbour Online publication only About Flatiron Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
Washington Post
15-05-2025
- Entertainment
- Washington Post
The author of ‘American Dirt' again considers the pain of displacement
In early 2020, Jeanine Cummins's novel 'American Dirt' was released with fanfare. It had been sold to publisher Flatiron for seven figures in a bidding war and acquired glowing endorsements from Stephen King and Sandra Cisneros. In response to the buzz, Flatiron set a first printing of half a million copies.
